
STAT Plus: FDA Commissioner Marty Makary gets off to a bruising start as agency is wracked by layoffs
Job cuts could compromise drug and device evaluation, agency transparency
Advertisement
Cancel anytime.
Subscribe nowOur Picks
Our Picks
NIH
NIH